Emancipation Management’s Eli Lilly LLY Stock Holding History

Emancipation Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,500	Closed	-$268K	–	29
2018 Q3	$268K	Hold	2,500	–	–	0.67%	22
2018 Q2	$213K	Buy	+2,500	New	+$205K	0.45%	28
2018 Q1	–	Sell	-2,500	Closed	-$211K	–	35
2017 Q4	$211K	Hold	2,500	–	–	0.35%	37
2017 Q3	$214K	Hold	2,500	–	–	0.31%	35
2017 Q2	$206K	Sell	2,500 -500	-17%	-$40.8K	0.34%	37
2017 Q1	$252K	Sell	3,000 -1,014	-25%	-$81.2K	0.38%	37
2016 Q4	$295K	Hold	4,014	–	–	0.48%	32
2016 Q3	$322K	Sell	4,014 -150	-4%	-$12K	0.5%	35
2016 Q2	$327K	Hold	4,164	–	–	0.4%	38
2016 Q1	$299K	Hold	4,164	–	–	0.39%	40
2015 Q4	$345K	Hold	4,164	–	–	0.32%	39
2015 Q3	$348K	Hold	4,164	–	–	0.33%	38
2015 Q2	$348K	Buy	+4,164	New	+$317K	0.29%	49

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Emancipation Management's LLY Position: Q4 2018 in Review

Emancipation Management sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 2,500 shares — an estimated $268K sold.

Emancipation Management first reported a position in LLY in Q2 2015 and held it in 13 quarters. The position peaked at $348K in Q3 2015. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

Emancipation Management reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
Emancipation Management sold 2,500 Eli Lilly shares in Q4 2018, an estimated $268K.
Emancipation Management first reported a position in Eli Lilly in Q2 2015 and held it in 13 quarters.
Emancipation Management's Eli Lilly position peaked at $348K in Q3 2015.
1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Emancipation Management's 13F filing for Q4 2018, filed 15 Feb 2019.